nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—Cisplatin—germ cell cancer	0.0874	0.12	CbGbCtD
Ezetimibe—ABCC3—Etoposide—germ cell cancer	0.0858	0.117	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—germ cell cancer	0.0641	0.0877	CbGbCtD
Ezetimibe—ABCG2—Dactinomycin—germ cell cancer	0.0625	0.0855	CbGbCtD
Ezetimibe—ABCC3—Methotrexate—germ cell cancer	0.0567	0.0776	CbGbCtD
Ezetimibe—ABCC2—Vinblastine—germ cell cancer	0.0433	0.0593	CbGbCtD
Ezetimibe—ABCC2—Cisplatin—germ cell cancer	0.0397	0.0543	CbGbCtD
Ezetimibe—ABCC2—Etoposide—germ cell cancer	0.039	0.0534	CbGbCtD
Ezetimibe—ABCG2—Cisplatin—germ cell cancer	0.0359	0.0491	CbGbCtD
Ezetimibe—ABCG2—Etoposide—germ cell cancer	0.0353	0.0483	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—germ cell cancer	0.0293	0.0401	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—germ cell cancer	0.0258	0.0353	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—germ cell cancer	0.0233	0.0319	CbGbCtD
Ezetimibe—ABCB1—Dactinomycin—germ cell cancer	0.0225	0.0308	CbGbCtD
Ezetimibe—CYP3A4—Ifosfamide—germ cell cancer	0.0159	0.0218	CbGbCtD
Ezetimibe—ABCB1—Vinblastine—germ cell cancer	0.0141	0.0193	CbGbCtD
Ezetimibe—ABCB1—Cisplatin—germ cell cancer	0.0129	0.0177	CbGbCtD
Ezetimibe—ABCB1—Etoposide—germ cell cancer	0.0127	0.0174	CbGbCtD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.0105	0.116	CbGpPWpGaD
Ezetimibe—CYP3A4—Vinblastine—germ cell cancer	0.00846	0.0116	CbGbCtD
Ezetimibe—ABCB1—Methotrexate—germ cell cancer	0.0084	0.0115	CbGbCtD
Ezetimibe—CYP3A4—Etoposide—germ cell cancer	0.00762	0.0104	CbGbCtD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00578	0.0634	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00554	0.0608	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00533	0.0585	CbGpPWpGaD
Ezetimibe—NPC1L1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00509	0.0559	CbGpPWpGaD
Ezetimibe—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00468	0.0514	CbGpPWpGaD
Ezetimibe—ABCG8—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00386	0.0424	CbGpPWpGaD
Ezetimibe—ABCG5—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00372	0.0408	CbGpPWpGaD
Ezetimibe—UGT1A1—urine—germ cell cancer	0.00345	0.0514	CbGeAlD
Ezetimibe—ANPEP—Peptide hormone metabolism—INHA—germ cell cancer	0.00323	0.0354	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.00296	0.0325	CbGpPWpGaD
Ezetimibe—ABCG5—endocrine gland—germ cell cancer	0.00294	0.0439	CbGeAlD
Ezetimibe—ANPEP—Peptide hormone metabolism—KLF4—germ cell cancer	0.00288	0.0316	CbGpPWpGaD
Ezetimibe—NPC1L1—endocrine gland—germ cell cancer	0.00277	0.0412	CbGeAlD
Ezetimibe—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00269	0.0295	CbGpPWpGaD
Ezetimibe—NPC1L1—testis—germ cell cancer	0.00264	0.0393	CbGeAlD
Ezetimibe—ABCG8—endocrine gland—germ cell cancer	0.00262	0.0391	CbGeAlD
Ezetimibe—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00253	0.0278	CbGpPWpGaD
Ezetimibe—SOAT1—trigeminal ganglion—germ cell cancer	0.00191	0.0285	CbGeAlD
Ezetimibe—ANPEP—trigeminal ganglion—germ cell cancer	0.00183	0.0273	CbGeAlD
Ezetimibe—ANPEP—embryo—germ cell cancer	0.00177	0.0263	CbGeAlD
Ezetimibe—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.00174	0.0191	CbGpPWpGaD
Ezetimibe—SOAT1—retina—germ cell cancer	0.00163	0.0243	CbGeAlD
Ezetimibe—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	0.00148	0.0162	CbGpPWpGaD
Ezetimibe—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00145	0.016	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.00145	0.0159	CbGpPWpGaD
Ezetimibe—SOAT1—decidua—germ cell cancer	0.00142	0.0212	CbGeAlD
Ezetimibe—ANPEP—skin of body—germ cell cancer	0.00137	0.0204	CbGeAlD
Ezetimibe—ANPEP—decidua—germ cell cancer	0.00136	0.0203	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.00134	0.0147	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transport of organic anions—AVP—germ cell cancer	0.00126	0.0138	CbGpPWpGaD
Ezetimibe—SOAT1—gonad—germ cell cancer	0.00125	0.0187	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—KITLG—germ cell cancer	0.00123	0.0135	CbGpPWpGaD
Ezetimibe—SOAT1—pituitary gland—germ cell cancer	0.00122	0.0182	CbGeAlD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.00122	0.0134	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.0012	0.0132	CbGpPWpGaD
Ezetimibe—ANPEP—uterus—germ cell cancer	0.00119	0.0178	CbGeAlD
Ezetimibe—UGT1A3—endocrine gland—germ cell cancer	0.00117	0.0175	CbGeAlD
Ezetimibe—ANPEP—pituitary gland—germ cell cancer	0.00117	0.0174	CbGeAlD
Ezetimibe—ANPEP—medulla oblongata—germ cell cancer	0.00113	0.0168	CbGeAlD
Ezetimibe—CYP3A4—urine—germ cell cancer	0.00111	0.0165	CbGeAlD
Ezetimibe—UGT2B15—endocrine gland—germ cell cancer	0.0011	0.0164	CbGeAlD
Ezetimibe—SOAT1—adrenal gland—germ cell cancer	0.00109	0.0163	CbGeAlD
Ezetimibe—SOAT1—bone marrow—germ cell cancer	0.00106	0.0158	CbGeAlD
Ezetimibe—SOAT1—spinal cord—germ cell cancer	0.00105	0.0157	CbGeAlD
Ezetimibe—ANPEP—adrenal gland—germ cell cancer	0.00105	0.0156	CbGeAlD
Ezetimibe—SOAT1—female gonad—germ cell cancer	0.00102	0.0152	CbGeAlD
Ezetimibe—ANPEP—bone marrow—germ cell cancer	0.00101	0.0151	CbGeAlD
Ezetimibe—ANPEP—female gonad—germ cell cancer	0.000975	0.0145	CbGeAlD
Ezetimibe—SOAT1—endocrine gland—germ cell cancer	0.000948	0.0141	CbGeAlD
Ezetimibe—SOAT1—head—germ cell cancer	0.000936	0.0139	CbGeAlD
Ezetimibe—ANPEP—endocrine gland—germ cell cancer	0.000907	0.0135	CbGeAlD
Ezetimibe—SOAT1—testis—germ cell cancer	0.000904	0.0135	CbGeAlD
Ezetimibe—ANPEP—head—germ cell cancer	0.000895	0.0133	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000885	0.00971	CbGpPWpGaD
Ezetimibe—ANPEP—testis—germ cell cancer	0.000865	0.0129	CbGeAlD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000852	0.00935	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—KIT—germ cell cancer	0.000842	0.00924	CbGpPWpGaD
Ezetimibe—SOAT1—cerebellum—germ cell cancer	0.000835	0.0124	CbGeAlD
Ezetimibe—ABCC3—decidua—germ cell cancer	0.000679	0.0101	CbGeAlD
Ezetimibe—SOAT1—brain—germ cell cancer	0.000678	0.0101	CbGeAlD
Ezetimibe—UGT2B7—endocrine gland—germ cell cancer	0.000673	0.01	CbGeAlD
Ezetimibe—SOAT1—lymph node—germ cell cancer	0.000655	0.00976	CbGeAlD
Ezetimibe—ANPEP—brain—germ cell cancer	0.000649	0.00966	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000645	0.00708	CbGpPWpGaD
Ezetimibe—UGT2B7—testis—germ cell cancer	0.000642	0.00956	CbGeAlD
Ezetimibe—ANPEP—lymph node—germ cell cancer	0.000627	0.00934	CbGeAlD
Ezetimibe—ANPEP—Metabolism of proteins—INHA—germ cell cancer	0.00061	0.00669	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000579	0.00635	CbGpPWpGaD
Ezetimibe—UGT1A1—endocrine gland—germ cell cancer	0.000572	0.00853	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00057	0.00626	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000557	0.00612	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000549	0.00602	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000545	0.00599	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—KLF4—germ cell cancer	0.000543	0.00596	CbGpPWpGaD
Ezetimibe—ABCG2—trigeminal ganglion—germ cell cancer	0.000531	0.00792	CbGeAlD
Ezetimibe—ABCC3—adrenal gland—germ cell cancer	0.000521	0.00776	CbGeAlD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000489	0.00537	CbGpPWpGaD
Ezetimibe—ABCC3—female gonad—germ cell cancer	0.000486	0.00724	CbGeAlD
Ezetimibe—SLCO1B1—endocrine gland—germ cell cancer	0.000476	0.00709	CbGeAlD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000471	0.00516	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000468	0.00513	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC2A3—germ cell cancer	0.000464	0.00509	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	0.000464	0.00509	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—MYC—germ cell cancer	0.000463	0.00508	CbGpPWpGaD
Ezetimibe—ABCC3—endocrine gland—germ cell cancer	0.000452	0.00673	CbGeAlD
Ezetimibe—ABCC3—head—germ cell cancer	0.000446	0.00665	CbGeAlD
Ezetimibe—ABCC3—testis—germ cell cancer	0.000431	0.00642	CbGeAlD
Ezetimibe—ABCB1—blood vessel—germ cell cancer	0.000424	0.00632	CbGeAlD
Ezetimibe—ABCG2—telencephalon—germ cell cancer	0.000417	0.00622	CbGeAlD
Ezetimibe—Angiopathy—Ifosfamide—germ cell cancer	0.000417	0.00376	CcSEcCtD
Ezetimibe—ABCC2—adrenal gland—germ cell cancer	0.000416	0.0062	CbGeAlD
Ezetimibe—Immune system disorder—Ifosfamide—germ cell cancer	0.000415	0.00374	CcSEcCtD
Ezetimibe—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000414	0.00373	CcSEcCtD
Ezetimibe—Cough—Bleomycin—germ cell cancer	0.000408	0.00368	CcSEcCtD
Ezetimibe—Paraesthesia—Vinblastine—germ cell cancer	0.000406	0.00366	CcSEcCtD
Ezetimibe—Alopecia—Ifosfamide—germ cell cancer	0.000406	0.00366	CcSEcCtD
Ezetimibe—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000405	0.00365	CcSEcCtD
Ezetimibe—Infestation—Etoposide—germ cell cancer	0.000404	0.00364	CcSEcCtD
Ezetimibe—Infestation NOS—Etoposide—germ cell cancer	0.000404	0.00364	CcSEcCtD
Ezetimibe—Anaemia—Dactinomycin—germ cell cancer	0.000403	0.00364	CcSEcCtD
Ezetimibe—Mental disorder—Ifosfamide—germ cell cancer	0.000403	0.00363	CcSEcCtD
Ezetimibe—Malnutrition—Ifosfamide—germ cell cancer	0.0004	0.0036	CcSEcCtD
Ezetimibe—Erythema—Ifosfamide—germ cell cancer	0.0004	0.0036	CcSEcCtD
Ezetimibe—Myalgia—Bleomycin—germ cell cancer	0.000398	0.00359	CcSEcCtD
Ezetimibe—Chest pain—Bleomycin—germ cell cancer	0.000398	0.00359	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Etoposide—germ cell cancer	0.000396	0.00357	CcSEcCtD
Ezetimibe—ABCG2—decidua—germ cell cancer	0.000396	0.00589	CbGeAlD
Ezetimibe—Jaundice—Etoposide—germ cell cancer	0.000394	0.00355	CcSEcCtD
Ezetimibe—Discomfort—Bleomycin—germ cell cancer	0.000394	0.00355	CcSEcCtD
Ezetimibe—Malaise—Dactinomycin—germ cell cancer	0.000394	0.00355	CcSEcCtD
Ezetimibe—Decreased appetite—Vinblastine—germ cell cancer	0.000393	0.00354	CcSEcCtD
Ezetimibe—Connective tissue disorder—Cisplatin—germ cell cancer	0.000389	0.00351	CcSEcCtD
Ezetimibe—Constipation—Vinblastine—germ cell cancer	0.000387	0.00349	CcSEcCtD
Ezetimibe—Pain—Vinblastine—germ cell cancer	0.000387	0.00349	CcSEcCtD
Ezetimibe—Confusional state—Bleomycin—germ cell cancer	0.000385	0.00347	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Etoposide—germ cell cancer	0.000382	0.00345	CcSEcCtD
Ezetimibe—Anaphylactic shock—Bleomycin—germ cell cancer	0.000382	0.00344	CcSEcCtD
Ezetimibe—Infection—Bleomycin—germ cell cancer	0.000379	0.00342	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—SLC2A3—germ cell cancer	0.000377	0.00414	CbGpPWpGaD
Ezetimibe—Thrombocytopenia—Bleomycin—germ cell cancer	0.000374	0.00337	CcSEcCtD
Ezetimibe—Feeling abnormal—Vinblastine—germ cell cancer	0.000373	0.00336	CcSEcCtD
Ezetimibe—Myalgia—Dactinomycin—germ cell cancer	0.000372	0.00335	CcSEcCtD
Ezetimibe—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000371	0.00334	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00037	0.00333	CcSEcCtD
Ezetimibe—Anaemia—Ifosfamide—germ cell cancer	0.00037	0.00333	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000368	0.00403	CbGpPWpGaD
Ezetimibe—Flushing—Cisplatin—germ cell cancer	0.000368	0.00331	CcSEcCtD
Ezetimibe—Discomfort—Dactinomycin—germ cell cancer	0.000367	0.00331	CcSEcCtD
Ezetimibe—Angioedema—Ifosfamide—germ cell cancer	0.000365	0.00329	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—HRAS—germ cell cancer	0.000364	0.00399	CbGpPWpGaD
Ezetimibe—ABCC2—endocrine gland—germ cell cancer	0.000361	0.00538	CbGeAlD
Ezetimibe—Malaise—Ifosfamide—germ cell cancer	0.000361	0.00325	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—SLC2A3—germ cell cancer	0.000358	0.00393	CbGpPWpGaD
Ezetimibe—Photosensitivity—Methotrexate—germ cell cancer	0.000358	0.00323	CcSEcCtD
Ezetimibe—Immune system disorder—Cisplatin—germ cell cancer	0.000358	0.00322	CcSEcCtD
Ezetimibe—Abdominal pain—Vinblastine—germ cell cancer	0.000357	0.00322	CcSEcCtD
Ezetimibe—Mediastinal disorder—Cisplatin—germ cell cancer	0.000357	0.00322	CcSEcCtD
Ezetimibe—Infection—Dactinomycin—germ cell cancer	0.000354	0.00319	CcSEcCtD
Ezetimibe—Palpitations—Ifosfamide—germ cell cancer	0.000353	0.00319	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—SLC22A3—germ cell cancer	0.000352	0.00387	CbGpPWpGaD
Ezetimibe—Alopecia—Cisplatin—germ cell cancer	0.00035	0.00315	CcSEcCtD
Ezetimibe—Hepatic failure—Methotrexate—germ cell cancer	0.00035	0.00315	CcSEcCtD
Ezetimibe—Cough—Ifosfamide—germ cell cancer	0.000349	0.00315	CcSEcCtD
Ezetimibe—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000349	0.00314	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000348	0.00314	CcSEcCtD
Ezetimibe—ABCG2—uterus—germ cell cancer	0.000346	0.00516	CbGeAlD
Ezetimibe—Hypertension—Ifosfamide—germ cell cancer	0.000345	0.00311	CcSEcCtD
Ezetimibe—Erythema—Cisplatin—germ cell cancer	0.000345	0.00311	CcSEcCtD
Ezetimibe—Malnutrition—Cisplatin—germ cell cancer	0.000345	0.00311	CcSEcCtD
Ezetimibe—ABCC2—testis—germ cell cancer	0.000344	0.00513	CbGeAlD
Ezetimibe—Erythema multiforme—Etoposide—germ cell cancer	0.000343	0.00309	CcSEcCtD
Ezetimibe—Paraesthesia—Bleomycin—germ cell cancer	0.000343	0.00309	CcSEcCtD
Ezetimibe—Dyspnoea—Bleomycin—germ cell cancer	0.000341	0.00307	CcSEcCtD
Ezetimibe—Myalgia—Ifosfamide—germ cell cancer	0.000341	0.00307	CcSEcCtD
Ezetimibe—Chest pain—Ifosfamide—germ cell cancer	0.000341	0.00307	CcSEcCtD
Ezetimibe—Arthralgia—Ifosfamide—germ cell cancer	0.000341	0.00307	CcSEcCtD
Ezetimibe—ABCG2—pituitary gland—germ cell cancer	0.00034	0.00506	CbGeAlD
Ezetimibe—Flatulence—Cisplatin—germ cell cancer	0.00034	0.00306	CcSEcCtD
Ezetimibe—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000339	0.00372	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000338	0.00305	CcSEcCtD
Ezetimibe—Flushing—Etoposide—germ cell cancer	0.000337	0.00304	CcSEcCtD
Ezetimibe—Discomfort—Ifosfamide—germ cell cancer	0.000336	0.00303	CcSEcCtD
Ezetimibe—Hypersensitivity—Vinblastine—germ cell cancer	0.000333	0.003	CcSEcCtD
Ezetimibe—Decreased appetite—Bleomycin—germ cell cancer	0.000332	0.00299	CcSEcCtD
Ezetimibe—Muscle spasms—Cisplatin—germ cell cancer	0.000332	0.00299	CcSEcCtD
Ezetimibe—Angiopathy—Etoposide—germ cell cancer	0.000329	0.00297	CcSEcCtD
Ezetimibe—Confusional state—Ifosfamide—germ cell cancer	0.000329	0.00297	CcSEcCtD
Ezetimibe—ABCG2—medulla oblongata—germ cell cancer	0.000328	0.00489	CbGeAlD
Ezetimibe—Immune system disorder—Etoposide—germ cell cancer	0.000328	0.00295	CcSEcCtD
Ezetimibe—Mediastinal disorder—Etoposide—germ cell cancer	0.000327	0.00295	CcSEcCtD
Ezetimibe—Pain—Bleomycin—germ cell cancer	0.000327	0.00294	CcSEcCtD
Ezetimibe—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000326	0.00294	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000325	0.00293	CcSEcCtD
Ezetimibe—Asthenia—Vinblastine—germ cell cancer	0.000324	0.00292	CcSEcCtD
Ezetimibe—Infection—Ifosfamide—germ cell cancer	0.000324	0.00292	CcSEcCtD
Ezetimibe—ABCC3—brain—germ cell cancer	0.000323	0.00482	CbGeAlD
Ezetimibe—Alopecia—Etoposide—germ cell cancer	0.000321	0.00289	CcSEcCtD
Ezetimibe—Nervous system disorder—Ifosfamide—germ cell cancer	0.00032	0.00289	CcSEcCtD
Ezetimibe—Ill-defined disorder—Cisplatin—germ cell cancer	0.00032	0.00288	CcSEcCtD
Ezetimibe—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00032	0.00288	CcSEcCtD
Ezetimibe—Anaemia—Cisplatin—germ cell cancer	0.000319	0.00287	CcSEcCtD
Ezetimibe—Skin disorder—Ifosfamide—germ cell cancer	0.000317	0.00286	CcSEcCtD
Ezetimibe—Feeling abnormal—Bleomycin—germ cell cancer	0.000315	0.00284	CcSEcCtD
Ezetimibe—ABCC3—lymph node—germ cell cancer	0.000312	0.00465	CbGeAlD
Ezetimibe—Malaise—Cisplatin—germ cell cancer	0.000311	0.0028	CcSEcCtD
Ezetimibe—Decreased appetite—Dactinomycin—germ cell cancer	0.00031	0.00279	CcSEcCtD
Ezetimibe—Diarrhoea—Vinblastine—germ cell cancer	0.000309	0.00279	CcSEcCtD
Ezetimibe—Fatigue—Dactinomycin—germ cell cancer	0.000307	0.00277	CcSEcCtD
Ezetimibe—Back pain—Etoposide—germ cell cancer	0.000306	0.00275	CcSEcCtD
Ezetimibe—Pain—Dactinomycin—germ cell cancer	0.000305	0.00275	CcSEcCtD
Ezetimibe—Muscle spasms—Etoposide—germ cell cancer	0.000304	0.00274	CcSEcCtD
Ezetimibe—ABCG2—adrenal gland—germ cell cancer	0.000304	0.00452	CbGeAlD
Ezetimibe—Urticaria—Bleomycin—germ cell cancer	0.000303	0.00273	CcSEcCtD
Ezetimibe—Body temperature increased—Bleomycin—germ cell cancer	0.000302	0.00272	CcSEcCtD
Ezetimibe—ABCG2—midbrain—germ cell cancer	0.0003	0.00447	CbGeAlD
Ezetimibe—Dizziness—Vinblastine—germ cell cancer	0.000299	0.0027	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000297	0.00268	CcSEcCtD
Ezetimibe—ABCG2—bone marrow—germ cell cancer	0.000294	0.00438	CbGeAlD
Ezetimibe—Myalgia—Cisplatin—germ cell cancer	0.000294	0.00265	CcSEcCtD
Ezetimibe—Feeling abnormal—Dactinomycin—germ cell cancer	0.000294	0.00265	CcSEcCtD
Ezetimibe—Paraesthesia—Ifosfamide—germ cell cancer	0.000293	0.00264	CcSEcCtD
Ezetimibe—Ill-defined disorder—Etoposide—germ cell cancer	0.000293	0.00264	CcSEcCtD
Ezetimibe—ABCG2—spinal cord—germ cell cancer	0.000292	0.00436	CbGeAlD
Ezetimibe—Anaemia—Etoposide—germ cell cancer	0.000292	0.00263	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000292	0.00263	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000291	0.00263	CcSEcCtD
Ezetimibe—Dyspnoea—Ifosfamide—germ cell cancer	0.000291	0.00262	CcSEcCtD
Ezetimibe—Liver function test abnormal—Methotrexate—germ cell cancer	0.00029	0.00261	CcSEcCtD
Ezetimibe—Discomfort—Cisplatin—germ cell cancer	0.00029	0.00261	CcSEcCtD
Ezetimibe—Vomiting—Vinblastine—germ cell cancer	0.000288	0.00259	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—CRABP1—germ cell cancer	0.000287	0.00315	CbGpPWpGaD
Ezetimibe—Malaise—Etoposide—germ cell cancer	0.000285	0.00257	CcSEcCtD
Ezetimibe—Breast disorder—Methotrexate—germ cell cancer	0.000284	0.00256	CcSEcCtD
Ezetimibe—Decreased appetite—Ifosfamide—germ cell cancer	0.000284	0.00256	CcSEcCtD
Ezetimibe—Headache—Vinblastine—germ cell cancer	0.000283	0.00255	CcSEcCtD
Ezetimibe—ABCG2—female gonad—germ cell cancer	0.000283	0.00422	CbGeAlD
Ezetimibe—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000282	0.00254	CcSEcCtD
Ezetimibe—Abdominal pain—Dactinomycin—germ cell cancer	0.000282	0.00254	CcSEcCtD
Ezetimibe—Body temperature increased—Dactinomycin—germ cell cancer	0.000282	0.00254	CcSEcCtD
Ezetimibe—Fatigue—Ifosfamide—germ cell cancer	0.000281	0.00254	CcSEcCtD
Ezetimibe—Anaphylactic shock—Cisplatin—germ cell cancer	0.000281	0.00254	CcSEcCtD
Ezetimibe—Hypersensitivity—Bleomycin—germ cell cancer	0.000281	0.00254	CcSEcCtD
Ezetimibe—Infection—Cisplatin—germ cell cancer	0.00028	0.00252	CcSEcCtD
Ezetimibe—Constipation—Ifosfamide—germ cell cancer	0.000279	0.00252	CcSEcCtD
Ezetimibe—Pain—Ifosfamide—germ cell cancer	0.000279	0.00252	CcSEcCtD
Ezetimibe—Nervous system disorder—Cisplatin—germ cell cancer	0.000276	0.00249	CcSEcCtD
Ezetimibe—Cough—Etoposide—germ cell cancer	0.000276	0.00248	CcSEcCtD
Ezetimibe—Thrombocytopenia—Cisplatin—germ cell cancer	0.000276	0.00248	CcSEcCtD
Ezetimibe—Asthenia—Bleomycin—germ cell cancer	0.000274	0.00247	CcSEcCtD
Ezetimibe—Skin disorder—Cisplatin—germ cell cancer	0.000273	0.00246	CcSEcCtD
Ezetimibe—Hypertension—Etoposide—germ cell cancer	0.000273	0.00246	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—SLC2A3—germ cell cancer	0.000271	0.00298	CbGpPWpGaD
Ezetimibe—Pruritus—Bleomycin—germ cell cancer	0.00027	0.00244	CcSEcCtD
Ezetimibe—Feeling abnormal—Ifosfamide—germ cell cancer	0.000269	0.00242	CcSEcCtD
Ezetimibe—Chest pain—Etoposide—germ cell cancer	0.000269	0.00242	CcSEcCtD
Ezetimibe—Eosinophilia—Methotrexate—germ cell cancer	0.000269	0.00242	CcSEcCtD
Ezetimibe—Nausea—Vinblastine—germ cell cancer	0.000269	0.00242	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—SLC22A3—germ cell cancer	0.000267	0.00293	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000267	0.00241	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000267	0.00293	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000267	0.00241	CcSEcCtD
Ezetimibe—Pancreatitis—Methotrexate—germ cell cancer	0.000266	0.0024	CcSEcCtD
Ezetimibe—Discomfort—Etoposide—germ cell cancer	0.000266	0.00239	CcSEcCtD
Ezetimibe—Hypersensitivity—Dactinomycin—germ cell cancer	0.000262	0.00237	CcSEcCtD
Ezetimibe—ABCB1—trigeminal ganglion—germ cell cancer	0.000262	0.0039	CbGeAlD
Ezetimibe—ABCG5—Metabolism—SLC2A3—germ cell cancer	0.000261	0.00286	CbGpPWpGaD
Ezetimibe—Confusional state—Etoposide—germ cell cancer	0.00026	0.00234	CcSEcCtD
Ezetimibe—Urticaria—Ifosfamide—germ cell cancer	0.000259	0.00234	CcSEcCtD
Ezetimibe—Body temperature increased—Ifosfamide—germ cell cancer	0.000258	0.00233	CcSEcCtD
Ezetimibe—Abdominal pain—Ifosfamide—germ cell cancer	0.000258	0.00233	CcSEcCtD
Ezetimibe—Anaphylactic shock—Etoposide—germ cell cancer	0.000258	0.00232	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—SLC22A3—germ cell cancer	0.000257	0.00282	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000257	0.00282	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000256	0.00231	CcSEcCtD
Ezetimibe—Infection—Etoposide—germ cell cancer	0.000256	0.00231	CcSEcCtD
Ezetimibe—Asthenia—Dactinomycin—germ cell cancer	0.000256	0.0023	CcSEcCtD
Ezetimibe—ABCB1—embryo—germ cell cancer	0.000253	0.00377	CbGeAlD
Ezetimibe—Paraesthesia—Cisplatin—germ cell cancer	0.000253	0.00228	CcSEcCtD
Ezetimibe—Thrombocytopenia—Etoposide—germ cell cancer	0.000252	0.00228	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000252	0.00227	CcSEcCtD
Ezetimibe—ABCG2—testis—germ cell cancer	0.000251	0.00374	CbGeAlD
Ezetimibe—Dyspnoea—Cisplatin—germ cell cancer	0.000251	0.00226	CcSEcCtD
Ezetimibe—Skin disorder—Etoposide—germ cell cancer	0.00025	0.00226	CcSEcCtD
Ezetimibe—Erectile dysfunction—Methotrexate—germ cell cancer	0.00025	0.00225	CcSEcCtD
Ezetimibe—ABCC2—lymph node—germ cell cancer	0.00025	0.00372	CbGeAlD
Ezetimibe—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000248	0.00223	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000247	0.00271	CbGpPWpGaD
Ezetimibe—Decreased appetite—Cisplatin—germ cell cancer	0.000245	0.0022	CcSEcCtD
Ezetimibe—Diarrhoea—Dactinomycin—germ cell cancer	0.000244	0.0022	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000243	0.00219	CcSEcCtD
Ezetimibe—Vomiting—Bleomycin—germ cell cancer	0.000243	0.00219	CcSEcCtD
Ezetimibe—Infestation NOS—Methotrexate—germ cell cancer	0.000242	0.00218	CcSEcCtD
Ezetimibe—Infestation—Methotrexate—germ cell cancer	0.000242	0.00218	CcSEcCtD
Ezetimibe—Rash—Bleomycin—germ cell cancer	0.000241	0.00217	CcSEcCtD
Ezetimibe—Pain—Cisplatin—germ cell cancer	0.000241	0.00217	CcSEcCtD
Ezetimibe—Dermatitis—Bleomycin—germ cell cancer	0.000241	0.00217	CcSEcCtD
Ezetimibe—Hypersensitivity—Ifosfamide—germ cell cancer	0.00024	0.00217	CcSEcCtD
Ezetimibe—Asthenia—Ifosfamide—germ cell cancer	0.000234	0.00211	CcSEcCtD
Ezetimibe—Feeling abnormal—Cisplatin—germ cell cancer	0.000232	0.00209	CcSEcCtD
Ezetimibe—ABCG2—cerebellum—germ cell cancer	0.000232	0.00345	CbGeAlD
Ezetimibe—Paraesthesia—Etoposide—germ cell cancer	0.000231	0.00209	CcSEcCtD
Ezetimibe—Pruritus—Ifosfamide—germ cell cancer	0.000231	0.00208	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—germ cell cancer	0.00023	0.00207	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000229	0.00206	CcSEcCtD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000227	0.00249	CbGpPWpGaD
Ezetimibe—Nausea—Bleomycin—germ cell cancer	0.000227	0.00204	CcSEcCtD
Ezetimibe—Vomiting—Dactinomycin—germ cell cancer	0.000226	0.00204	CcSEcCtD
Ezetimibe—Rash—Dactinomycin—germ cell cancer	0.000225	0.00202	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—germ cell cancer	0.000224	0.00202	CcSEcCtD
Ezetimibe—ABCB1—retina—germ cell cancer	0.000224	0.00333	CbGeAlD
Ezetimibe—Diarrhoea—Ifosfamide—germ cell cancer	0.000223	0.00201	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000223	0.00201	CcSEcCtD
Ezetimibe—Body temperature increased—Cisplatin—germ cell cancer	0.000222	0.00201	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—germ cell cancer	0.000222	0.002	CcSEcCtD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000222	0.00243	CbGpPWpGaD
Ezetimibe—Pain—Etoposide—germ cell cancer	0.00022	0.00199	CcSEcCtD
Ezetimibe—Constipation—Etoposide—germ cell cancer	0.00022	0.00199	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—CRABP1—germ cell cancer	0.000218	0.00239	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000218	0.00239	CbGpPWpGaD
Ezetimibe—Hepatitis—Methotrexate—germ cell cancer	0.000217	0.00196	CcSEcCtD
Ezetimibe—Dizziness—Ifosfamide—germ cell cancer	0.000216	0.00195	CcSEcCtD
Ezetimibe—Pharyngitis—Methotrexate—germ cell cancer	0.000216	0.00194	CcSEcCtD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000214	0.00235	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Etoposide—germ cell cancer	0.000212	0.00191	CcSEcCtD
Ezetimibe—Nausea—Dactinomycin—germ cell cancer	0.000212	0.00191	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—germ cell cancer	0.000211	0.0019	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—CRABP1—germ cell cancer	0.00021	0.0023	CbGpPWpGaD
Ezetimibe—Vomiting—Ifosfamide—germ cell cancer	0.000208	0.00187	CcSEcCtD
Ezetimibe—Hypersensitivity—Cisplatin—germ cell cancer	0.000207	0.00187	CcSEcCtD
Ezetimibe—ABCB1—telencephalon—germ cell cancer	0.000206	0.00307	CbGeAlD
Ezetimibe—Rash—Ifosfamide—germ cell cancer	0.000206	0.00186	CcSEcCtD
Ezetimibe—Dermatitis—Ifosfamide—germ cell cancer	0.000206	0.00185	CcSEcCtD
Ezetimibe—Erythema multiforme—Methotrexate—germ cell cancer	0.000206	0.00185	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—germ cell cancer	0.000205	0.00185	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—germ cell cancer	0.000204	0.00184	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—germ cell cancer	0.000204	0.00184	CcSEcCtD
Ezetimibe—Asthenia—Cisplatin—germ cell cancer	0.000202	0.00182	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—germ cell cancer	0.000197	0.00178	CcSEcCtD
Ezetimibe—Immune system disorder—Methotrexate—germ cell cancer	0.000196	0.00177	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—germ cell cancer	0.000196	0.00177	CcSEcCtD
Ezetimibe—ABCB1—decidua—germ cell cancer	0.000195	0.00291	CbGeAlD
Ezetimibe—Nausea—Ifosfamide—germ cell cancer	0.000194	0.00175	CcSEcCtD
Ezetimibe—Diarrhoea—Cisplatin—germ cell cancer	0.000193	0.00174	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—germ cell cancer	0.000192	0.00173	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—germ cell cancer	0.00019	0.00172	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—germ cell cancer	0.00019	0.00171	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—germ cell cancer	0.000189	0.00171	CcSEcCtD
Ezetimibe—Erythema—Methotrexate—germ cell cancer	0.000189	0.00171	CcSEcCtD
Ezetimibe—ABCG2—brain—germ cell cancer	0.000188	0.00281	CbGeAlD
Ezetimibe—Asthenia—Etoposide—germ cell cancer	0.000185	0.00167	CcSEcCtD
Ezetimibe—CYP3A4—endocrine gland—germ cell cancer	0.000183	0.00273	CbGeAlD
Ezetimibe—Back pain—Methotrexate—germ cell cancer	0.000183	0.00165	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—germ cell cancer	0.000182	0.00164	CcSEcCtD
Ezetimibe—ABCG2—lymph node—germ cell cancer	0.000182	0.00271	CbGeAlD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00018	0.00198	CbGpPWpGaD
Ezetimibe—Vomiting—Cisplatin—germ cell cancer	0.000179	0.00161	CcSEcCtD
Ezetimibe—Rash—Cisplatin—germ cell cancer	0.000177	0.0016	CcSEcCtD
Ezetimibe—Dermatitis—Cisplatin—germ cell cancer	0.000177	0.0016	CcSEcCtD
Ezetimibe—Diarrhoea—Etoposide—germ cell cancer	0.000176	0.00159	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—germ cell cancer	0.000176	0.00158	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—germ cell cancer	0.000175	0.00158	CcSEcCtD
Ezetimibe—ABCB1—gonad—germ cell cancer	0.000172	0.00256	CbGeAlD
Ezetimibe—ABCB1—uterus—germ cell cancer	0.000171	0.00254	CbGeAlD
Ezetimibe—Malaise—Methotrexate—germ cell cancer	0.000171	0.00154	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—germ cell cancer	0.00017	0.00154	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000169	0.00186	CbGpPWpGaD
Ezetimibe—ABCB1—pituitary gland—germ cell cancer	0.000168	0.0025	CbGeAlD
Ezetimibe—Nausea—Cisplatin—germ cell cancer	0.000167	0.00151	CcSEcCtD
Ezetimibe—Cough—Methotrexate—germ cell cancer	0.000165	0.00149	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—germ cell cancer	0.000164	0.00148	CcSEcCtD
Ezetimibe—Rash—Etoposide—germ cell cancer	0.000163	0.00147	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—germ cell cancer	0.000162	0.00146	CcSEcCtD
Ezetimibe—ABCB1—medulla oblongata—germ cell cancer	0.000162	0.00241	CbGeAlD
Ezetimibe—Headache—Etoposide—germ cell cancer	0.000162	0.00146	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—germ cell cancer	0.000161	0.00145	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—germ cell cancer	0.000161	0.00145	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—germ cell cancer	0.000161	0.00145	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00016	0.00144	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—germ cell cancer	0.000159	0.00143	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000157	0.00172	CbGpPWpGaD
Ezetimibe—Confusional state—Methotrexate—germ cell cancer	0.000156	0.0014	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—germ cell cancer	0.000154	0.00139	CcSEcCtD
Ezetimibe—Infection—Methotrexate—germ cell cancer	0.000153	0.00138	CcSEcCtD
Ezetimibe—Nausea—Etoposide—germ cell cancer	0.000153	0.00138	CcSEcCtD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000153	0.00168	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SLC2A3—germ cell cancer	0.000153	0.00168	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Methotrexate—germ cell cancer	0.000151	0.00136	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—germ cell cancer	0.000151	0.00136	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—SLC22A3—germ cell cancer	0.00015	0.00165	CbGpPWpGaD
Ezetimibe—Skin disorder—Methotrexate—germ cell cancer	0.00015	0.00135	CcSEcCtD
Ezetimibe—ABCB1—adrenal gland—germ cell cancer	0.00015	0.00223	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000149	0.00163	CbGpPWpGaD
Ezetimibe—ABCB1—midbrain—germ cell cancer	0.000148	0.0022	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000146	0.00161	CbGpPWpGaD
Ezetimibe—ABCB1—bone marrow—germ cell cancer	0.000145	0.00216	CbGeAlD
Ezetimibe—ABCB1—spinal cord—germ cell cancer	0.000144	0.00215	CbGeAlD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000141	0.00127	CcSEcCtD
Ezetimibe—Insomnia—Methotrexate—germ cell cancer	0.00014	0.00126	CcSEcCtD
Ezetimibe—ABCB1—female gonad—germ cell cancer	0.00014	0.00208	CbGeAlD
Ezetimibe—Paraesthesia—Methotrexate—germ cell cancer	0.000139	0.00125	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—germ cell cancer	0.000138	0.00124	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—germ cell cancer	0.000136	0.00123	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000136	0.00149	CbGpPWpGaD
Ezetimibe—Decreased appetite—Methotrexate—germ cell cancer	0.000134	0.00121	CcSEcCtD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000133	0.00146	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000133	0.0012	CcSEcCtD
Ezetimibe—Fatigue—Methotrexate—germ cell cancer	0.000133	0.0012	CcSEcCtD
Ezetimibe—Pain—Methotrexate—germ cell cancer	0.000132	0.00119	CcSEcCtD
Ezetimibe—ABCB1—endocrine gland—germ cell cancer	0.00013	0.00193	CbGeAlD
Ezetimibe—ABCB1—head—germ cell cancer	0.000128	0.00191	CbGeAlD
Ezetimibe—Feeling abnormal—Methotrexate—germ cell cancer	0.000127	0.00115	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000126	0.00114	CcSEcCtD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000125	0.00138	CbGpPWpGaD
Ezetimibe—ABCB1—testis—germ cell cancer	0.000124	0.00184	CbGeAlD
Ezetimibe—Urticaria—Methotrexate—germ cell cancer	0.000123	0.00111	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—CRABP1—germ cell cancer	0.000123	0.00135	CbGpPWpGaD
Ezetimibe—Abdominal pain—Methotrexate—germ cell cancer	0.000122	0.0011	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—germ cell cancer	0.000122	0.0011	CcSEcCtD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000118	0.00129	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000116	0.00127	CbGpPWpGaD
Ezetimibe—ABCB1—cerebellum—germ cell cancer	0.000114	0.0017	CbGeAlD
Ezetimibe—Hypersensitivity—Methotrexate—germ cell cancer	0.000114	0.00103	CcSEcCtD
Ezetimibe—Asthenia—Methotrexate—germ cell cancer	0.000111	0.000999	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000111	0.00121	CbGpPWpGaD
Ezetimibe—Pruritus—Methotrexate—germ cell cancer	0.000109	0.000985	CcSEcCtD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000109	0.0012	CbGpPWpGaD
Ezetimibe—Diarrhoea—Methotrexate—germ cell cancer	0.000106	0.000952	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000102	0.00112	CbGpPWpGaD
Ezetimibe—Dizziness—Methotrexate—germ cell cancer	0.000102	0.00092	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000101	0.00111	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.0001	0.0011	CbGpPWpGaD
Ezetimibe—Vomiting—Methotrexate—germ cell cancer	9.82e-05	0.000885	CcSEcCtD
Ezetimibe—Rash—Methotrexate—germ cell cancer	9.74e-05	0.000878	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—germ cell cancer	9.73e-05	0.000877	CcSEcCtD
Ezetimibe—Headache—Methotrexate—germ cell cancer	9.67e-05	0.000872	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.34e-05	0.00102	CbGpPWpGaD
Ezetimibe—ABCB1—brain—germ cell cancer	9.29e-05	0.00138	CbGeAlD
Ezetimibe—Nausea—Methotrexate—germ cell cancer	9.17e-05	0.000827	CcSEcCtD
Ezetimibe—ABCB1—lymph node—germ cell cancer	8.97e-05	0.00134	CbGeAlD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.46e-05	0.000929	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC2A3—germ cell cancer	8.18e-05	0.000898	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC22A3—germ cell cancer	8.06e-05	0.000884	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	7.34e-05	0.000805	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC2A3—germ cell cancer	6.96e-05	0.000763	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC2A3—germ cell cancer	6.96e-05	0.000763	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC22A3—germ cell cancer	6.85e-05	0.000752	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC22A3—germ cell cancer	6.85e-05	0.000752	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—AVP—germ cell cancer	6.85e-05	0.000752	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CRABP1—germ cell cancer	6.57e-05	0.000721	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC2A3—germ cell cancer	5.65e-05	0.00062	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CRABP1—germ cell cancer	5.59e-05	0.000613	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CRABP1—germ cell cancer	5.59e-05	0.000613	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC22A3—germ cell cancer	5.57e-05	0.000611	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.54e-05	0.000608	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.45e-05	0.000598	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	5.43e-05	0.000596	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	5.18e-05	0.000568	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	5.1e-05	0.00056	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.1e-05	0.00056	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC2A3—germ cell cancer	4.8e-05	0.000526	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC22A3—germ cell cancer	4.72e-05	0.000518	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.72e-05	0.000518	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CRABP1—germ cell cancer	4.54e-05	0.000498	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CRABP1—germ cell cancer	4.16e-05	0.000456	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CRABP1—germ cell cancer	3.85e-05	0.000423	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.59e-05	0.000285	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.55e-05	0.00028	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.55e-05	0.00028	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.47e-05	0.000271	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CRABP1—germ cell cancer	2.08e-05	0.000228	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.03e-05	0.000223	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.6e-05	0.000175	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.57e-05	0.000173	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.28e-05	0.000141	CbGpPWpGaD
